Some people continue to have slightly looser stools than their pre-retatrutide baseline, which is a minor adaptation most find acceptable given the weight loss benefits
STEP 2 Meet your Team A health specialist will contact you within 24-48 hours to review your form, discuss your symptoms, goals, and need for lab work
Guidance such as the ADA/EASD Management of hyperglycaemia in type 2 diabetes consensus report (Davies et al, 2022) recommends early initiation of GLP-1 RAs or SGLT2 inhibitors along with metformin in those with established or high risk of cardiovascular disease, and it is usual practice to titrate one drug up fully before adding the second class, without waiting for further glycaemic assessment
Endpoint choice matters because a biomarker improvement is not the same as an approved clinical outcome
With well-documented insurance coverage, Wegovy emerges as a popular and reliable choice
Most patients begin noticing meaningful appetite reduction within the first two to four weeks, with measurable weight loss typically appearing by weeks four through eight